Home

binden langs Toeschouwer teva shares nyse hongersnood Actuator Kort geleden

Teva shares hit 19-year low after opioid settlement, analyst downgrades |  Fierce Pharma
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma

What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

With 61% ownership of the shares, Teva Pharmaceutical Industries Limited ( NYSE:TEVA) is heavily dominated by institutional owners
With 61% ownership of the shares, Teva Pharmaceutical Industries Limited ( NYSE:TEVA) is heavily dominated by institutional owners

TEVA: 1 Stock Warren Buffett Might Have Sold Too Soon
TEVA: 1 Stock Warren Buffett Might Have Sold Too Soon

Teva Pharmaceutical Industries Limited (TEVA) Stock 10 Year History
Teva Pharmaceutical Industries Limited (TEVA) Stock 10 Year History

Teva Pharmaceutical Industries Stock Forecast, Price & News (NYSE:TEVA)
Teva Pharmaceutical Industries Stock Forecast, Price & News (NYSE:TEVA)

Teva Pharmaceutical Indus Stock (NYSE:TEVA), Quotes and News Summary -  Benzinga
Teva Pharmaceutical Indus Stock (NYSE:TEVA), Quotes and News Summary - Benzinga

TEVA stock raised to Neutral at BofA citing a near-term opioid deal (NYSE: TEVA) | Seeking Alpha
TEVA stock raised to Neutral at BofA citing a near-term opioid deal (NYSE: TEVA) | Seeking Alpha

Teva Pharmaceutical Industries Limited (TEVA) Stock 5 Years History  [Returns & Performance]
Teva Pharmaceutical Industries Limited (TEVA) Stock 5 Years History [Returns & Performance]

TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE)  | Barron's
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's

Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli honored - The  Jerusalem Post
Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli honored - The Jerusalem Post

What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking  Alpha
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha

Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other  Stocks Moving In Friday's Mid-Day Session By Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session By Benzinga

Teva collapse continues on Wall Street - Globes
Teva collapse continues on Wall Street - Globes

A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd ( TEVA) Stock
A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd ( TEVA) Stock

Teva reaches $15m deal with Louisiana to settle opioid-related claims | The  Times of Israel
Teva reaches $15m deal with Louisiana to settle opioid-related claims | The Times of Israel

Teva Up 25% on NYSE Since Third Quarter Reports | Ctech
Teva Up 25% on NYSE Since Third Quarter Reports | Ctech

TEVA Plunges on Q1 Results - TipRanks.com
TEVA Plunges on Q1 Results - TipRanks.com

Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton,  Groupon & more
Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & more

Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley  Fool
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool

Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's  Business Daily
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum |  AlphaStreet
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet

Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com

Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) |  Seeking Alpha
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha